HighTower Advisors
CRVO icon

HighTower Advisors’s CervoMed CRVO Stock Holding History

HighTower Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33.4K Sell
11,244
-675
-6% -$1.88K ﹤0.01% 3773
2026
Q2 		$36.9K Buy
11,919
+654
+6% +$2.3K ﹤0.01% 3744
2026
Q1 		$44.4K Buy
11,265
+21
+0.2% +$110 ﹤0.01% 3715
2025
Q4 		$88.8K Hold
11,244
– – ﹤0.01% 3524
2025
Q3 		$91K Hold
11,244
– – ﹤0.01% 3555
2025
Q2 		$70.7K Sell
11,244
-100
-0.9% -$852 ﹤0.01% 3521
2025
Q1 		$104K Buy
+11,344
New +$43.2K ﹤0.01% 3349

Other funds holding CRVO

SM
Sabby Management Miami Beach, Florida $9.02M AUM 74.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Byrne Asset Management
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
Savvy Advisors Inc
Savvy Advisors Inc New York $6.03B AUM 17.97% 1-Year Est. Return
Thompson Davis & Co
Thompson Davis & Co Richmond, Virginia $149M AUM 10.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

HighTower Advisors's CRVO Position: Q3 2026 in Review

HighTower Advisors reduced its CervoMed (CRVO) stake by 5.7% in Q3 2026, selling an estimated $1.88K and leaving 11,244 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3773.

HighTower Advisors first reported a position in CRVO in Q1 2025 and has held it in 7 quarters since. The position peaked at $104K in Q1 2025. 22 funds tracked by Wall St. Rank hold CRVO as of Q3 2026.

  • HighTower Advisors held 11,244 shares of CervoMed worth $33.4K as of Q3 2026.
  • HighTower Advisors sold 675 CervoMed shares in Q3 2026, an estimated $1.88K.
  • CervoMed made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3773 holding.
  • HighTower Advisors first reported a position in CervoMed in Q1 2025 and has held it in 7 quarters since.
  • HighTower Advisors's CervoMed position peaked at $104K in Q1 2025.
  • 22 funds tracked by Wall St. Rank held CervoMed as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.